Fusion Pharmaceuticals Inc (FUSN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: FUSN Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2022-08-11 2022-08-11 B Purchase

GANNON STEVEN

Non-Executive Director
44,400 +370.0%
2.03
90,132 USD 		44,400 +370.0% 2.03 90,132 USD
2022-04-27 2022-04-27 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
4,511 -1.4%
6.03
27,201 USD 		4,511 -1.4% 6.03 27,201 USD
2022-04-27 2022-04-26 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
2,147 -0.7%
6.07
13,032 USD 		2,147 -0.7% 6.07 13,032 USD
2022-04-27 2022-04-25 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
2,036 -0.6%
6.03
12,277 USD 		2,036 -0.6% 6.03 12,277 USD
2022-04-22 2022-04-21 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
922 -0.3%
6.01
5,541 USD 		922 -0.3% 6.01 5,541 USD
2022-04-22 2022-04-20 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
367 -0.1%
6.02
2,209 USD 		367 -0.1% 6.02 2,209 USD
2022-04-13 2022-04-13 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
11,994 -3.5%
6.41
76,882 USD 		11,994 -3.5% 6.41 76,882 USD
2022-04-13 2022-04-12 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
18,255 -5.1%
7.10
129,611 USD 		18,255 -5.1% 7.10 129,611 USD
2022-04-13 2022-04-11 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
2,600 -0.7%
7.37
19,162 USD 		2,600 -0.7% 7.37 19,162 USD
2022-04-08 2022-04-08 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
826 -0.2%
7.52
6,212 USD 		826 -0.2% 7.52 6,212 USD
2022-04-08 2022-04-07 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
1,255 -0.3%
7.56
9,488 USD 		1,255 -0.3% 7.56 9,488 USD
2022-04-08 2022-04-06 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
7.58
758 USD 		100 -0.0% 7.58 758 USD
2022-04-05 2022-04-05 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
2,100 -0.6%
7.67
16,107 USD 		2,100 -0.6% 7.67 16,107 USD
2022-04-05 2022-04-04 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
700 -0.2%
7.81
5,467 USD 		700 -0.2% 7.81 5,467 USD
2022-04-05 2022-04-01 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
1,000 -0.3%
7.75
7,750 USD 		1,000 -0.3% 7.75 7,750 USD
2022-04-01 2022-03-30 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
300 -0.1%
7.52
2,256 USD 		300 -0.1% 7.52 2,256 USD
2022-03-29 2022-03-29 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
200 -0.1%
7.52
1,504 USD 		200 -0.1% 7.52 1,504 USD
2022-03-29 2022-03-28 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
9,600 -2.5%
7.55
72,480 USD 		9,600 -2.5% 7.55 72,480 USD
2022-03-29 2022-03-25 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
500 -0.1%
7.42
3,710 USD 		500 -0.1% 7.42 3,710 USD
2022-03-24 2022-03-23 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
7.50
750 USD 		100 -0.0% 7.50 750 USD
2022-03-24 2022-03-22 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
4,000 -1.0%
7.53
30,120 USD 		4,000 -1.0% 7.53 30,120 USD
2022-03-24 2022-03-21 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
700 -0.2%
7.46
5,222 USD 		700 -0.2% 7.46 5,222 USD
2022-03-21 2022-03-21 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
1,500 -0.4%
7.47
11,205 USD 		1,500 -0.4% 7.47 11,205 USD
2022-03-21 2022-03-18 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
1,204 -0.3%
7.61
9,162 USD 		1,204 -0.3% 7.61 9,162 USD
2022-03-21 2022-03-17 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
900 -0.2%
7.51
6,759 USD 		900 -0.2% 7.51 6,759 USD
2022-03-16 2022-03-16 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
6.99
699 USD 		100 -0.0% 6.99 699 USD
2022-03-16 2022-03-15 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
7.12
712 USD 		100 -0.0% 7.12 712 USD
2022-03-16 2022-03-14 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
1,300 -0.3%
6.96
9,048 USD 		1,300 -0.3% 6.96 9,048 USD
2022-03-14 2022-03-11 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
100 -0.0%
7.13
713 USD 		100 -0.0% 7.13 713 USD
2022-03-14 2022-03-10 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
1,900 -0.5%
7.06
13,414 USD 		1,900 -0.5% 7.06 13,414 USD
2022-03-14 2022-03-09 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
822 -0.2%
6.94
5,705 USD 		822 -0.2% 6.94 5,705 USD
2022-03-08 2022-03-08 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
3,004 -0.8%
6.92
20,788 USD 		3,004 -0.8% 6.92 20,788 USD
2022-03-08 2022-03-07 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
3,100 -0.8%
6.99
21,669 USD 		3,100 -0.8% 6.99 21,669 USD
2022-03-08 2022-03-04 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
8,400 -2.1%
7.32
61,488 USD 		8,400 -2.1% 7.32 61,488 USD
2022-03-03 2022-03-03 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
200 -0.0%
7.28
1,456 USD 		200 -0.0% 7.28 1,456 USD
2022-03-03 2022-03-02 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
26,546 -6.2%
7.44
197,502 USD 		26,546 -6.2% 7.44 197,502 USD
2022-03-03 2022-03-01 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
847 -0.2%
7.37
6,242 USD 		847 -0.2% 7.37 6,242 USD
2022-02-28 2022-02-28 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
3,100 -0.7%
7.40
22,940 USD 		3,100 -0.7% 7.40 22,940 USD
2022-02-28 2022-02-25 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
8,152 -1.8%
7.57
61,711 USD 		8,152 -1.8% 7.57 61,711 USD
2022-02-28 2022-02-24 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
2,500 -0.6%
7.41
18,525 USD 		2,500 -0.6% 7.41 18,525 USD
2022-02-23 2022-02-23 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
29,299 -6.2%
7.77
227,653 USD 		29,299 -6.2% 7.77 227,653 USD
2022-02-23 2022-02-22 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
4,100 -0.9%
7.85
32,185 USD 		4,100 -0.9% 7.85 32,185 USD
2022-02-23 2022-02-18 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
4,898 -1.0%
7.88
38,596 USD 		4,898 -1.0% 7.88 38,596 USD
2022-02-17 2022-02-17 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
1,700 -0.3%
7.98
13,566 USD 		1,700 -0.3% 7.98 13,566 USD
2022-02-17 2022-02-16 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
33,202 -6.4%
7.99
265,284 USD 		33,202 -6.4% 7.99 265,284 USD
2022-02-17 2022-02-15 PS Planned sale

Valliant John

Chief Executive Officer

Executive Director
12,600 -2.4%
8.33
104,958 USD 		12,600 -2.4% 8.33 104,958 USD
2021-08-20 2021-08-19 B Purchase

GANNON STEVEN

Non-Executive Director
3,000 +48.6%
8.05
24,150 USD 		3,000 +48.6% 8.05 24,150 USD
2021-08-20 2021-08-18 B Purchase

GANNON STEVEN

Non-Executive Director
171 +2.9%
8.05
1,377 USD 		171 +2.9% 8.05 1,377 USD
2020-12-29 2020-12-24 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
1,584 -0.1%
12.32
19,515 USD 		1,584 -0.1% 12.32 19,515 USD
2020-12-29 2020-12-24 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
681 -0.1%
12.32
8,390 USD 		681 -0.1% 12.32 8,390 USD
2020-12-29 2020-12-24 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
455 -0.1%
12.32
5,606 USD 		455 -0.1% 12.32 5,606 USD
2020-12-29 2020-12-24 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
469 -0.1%
12.32
5,778 USD 		469 -0.1% 12.32 5,778 USD
2020-12-29 2020-12-24 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
611 -0.1%
12.32
7,528 USD 		611 -0.1% 12.32 7,528 USD
2020-12-28 2020-12-23 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
1,905 -0.1%
12.39
23,603 USD 		1,905 -0.1% 12.39 23,603 USD
2020-12-28 2020-12-23 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
819 -0.1%
12.39
10,147 USD 		819 -0.1% 12.39 10,147 USD
2020-12-28 2020-12-23 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
547 -0.1%
12.39
6,777 USD 		547 -0.1% 12.39 6,777 USD
2020-12-28 2020-12-23 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
564 -0.1%
12.39
6,988 USD 		564 -0.1% 12.39 6,988 USD
2020-12-28 2020-12-23 S Sale

ADAMS STREET PARTNERS LLC

Large shareholder
734 -0.1%
12.39
9,094 USD 		734 -0.1% 12.39 9,094 USD
2020-07-02 2020-06-30 B Purchase

TPG Group Holdings (SBS) Advisors, Inc.

250,000 +10.9%
17.00
4,250,000 USD 		250,000 +10.9% 17.00 4,250,000 USD
2020-07-02 2020-06-30 B Purchase

Khuong Chau Quang

Non-Executive Director
192,100 +inf%
17.00
3,265,700 USD 		192,100 +inf% 17.00 3,265,700 USD
2020-07-02 2020-06-30 B Purchase

Khuong Chau Quang

Non-Executive Director
705,900 +31.7%
17.00
12,000,300 USD 		705,900 +31.7% 17.00 12,000,300 USD
2020-07-02 2020-06-30 B Purchase

Christenson Johan

Non-Executive Director
240,000 +6.7%
17.00
4,080,000 USD 		240,000 +6.7% 17.00 4,080,000 USD
2020-07-02 2020-06-30 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director
192,100 +inf%
17.00
3,265,700 USD 		192,100 +inf% 17.00 3,265,700 USD
2020-07-02 2020-06-30 B Purchase

ORBIMED ADVISORS LLC

Non-Executive Director
705,900 +31.7%
17.00
12,000,300 USD 		705,900 +31.7% 17.00 12,000,300 USD
2020-07-02 2020-06-30 B Purchase

JOHNSON & JOHNSON

Large shareholder
725,000 +24.6%
17.00
12,325,000 USD 		725,000 +24.6% 17.00 12,325,000 USD
2020-07-02 2020-06-30 B Purchase

HealthCap VII, L.P.

Large shareholder
240,000 +6.7%
17.00
4,080,000 USD 		240,000 +6.7% 17.00 4,080,000 USD
2020-07-02 2020-06-30 B Purchase

O'Leary James J

Chief Medical Officer

Officer
300 +inf%
17.00
5,100 USD 		300 +inf% 17.00 5,100 USD
2020-07-02 2020-06-30 B Purchase

Preston Heather

Non-Executive Director
8,823 +inf%
17.00
149,991 USD 		8,823 +inf% 17.00 149,991 USD
2020-07-02 2020-06-30 B Purchase

Crowley John J

Chief Financial Officer

Officer
6,500 +inf%
17.00
110,500 USD 		6,500 +inf% 17.00 110,500 USD